RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
The Economics of TB Drug Development is a rigorous, authoritative source of information on the epidemiology of tuberculosis, potential market for new anti-TB drugs, costs of drug development, the potential return on investment, and options for funding and conducting drug development. Prepared by a variety of TB experts at public health agencies, research organisations, private pharmaceutical companies, and nongovernmental organisations (NGOs), under the auspices of the Global Alliance for TB Drug Development, this report provides essential data required for informed
investment decisions by industry, foundations, government organisations, and world.
health and financial organisations.